A multimodal deep learning system to distinguish late stages of AMD and to compare expert vs. AI ocu...
A multimodal deep learning system to distinguish late stages of AMD and to compare expert vs. AI ocular biomarkers
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Within the next 1.5 decades, 1 in 7 U.S. adults is anticipated to suffer from age-related macular degeneration (AMD), a degenerative retinal disease which leads to blindness if untreated. Optical coherence tomography angiography (OCTA) has become a prime technique for AMD diagnosis, specifically for late-stage neovascular (NV) AMD. Such technologie...
Alternative Titles
Full title
A multimodal deep learning system to distinguish late stages of AMD and to compare expert vs. AI ocular biomarkers
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_651cc9a0a69d429983ce065ff9784e8a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_651cc9a0a69d429983ce065ff9784e8a
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-022-06273-w
